{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:58:14Z","timestamp":1785862694583,"version":"3.56.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Willard B. Warring Memorial Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Peptides"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.regpep.2012.08.006","type":"journal-article","created":{"date-parts":[[2012,9,5]],"date-time":"2012-09-05T06:30:48Z","timestamp":1346826648000},"page":"33-38","source":"Crossref","is-referenced-by-count":23,"title":["[d-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, augments the effects of orally delivered exenatide and pramlintide acetate on energy balance and glycemic control in insulin-resistant male C57BLK\/6-m db\/db mice"],"prefix":"10.1016","volume":"179","author":[{"given":"Matthew C.","family":"Leinung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Grasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.regpep.2012.08.006_bb0005","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes","volume":"27","author":"Will","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.regpep.2012.08.006_bb0010","series-title":"Report of a WHO consultation on obesity","article-title":"Obesity: prevention and managing the global epidemic","author":"World Health Organization","year":"1997"},{"key":"10.1016\/j.regpep.2012.08.006_bb0015","first-page":"1066","article-title":"Prevalence of overweight and obesity among adults with diagnosed diabetes \u2013 United States, 1988\u20131994 and 1999\u20132002, MMWR","volume":"53","author":"Centers for Disease Control, Prevention (CDC)","year":"2004","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.regpep.2012.08.006_bb0020","first-page":"14","article-title":"Aging Americans and diabetes","volume":"59","author":"Jack","year":"2004","journal-title":"Geriatrics"},{"key":"10.1016\/j.regpep.2012.08.006_bb0025","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11892-002-0098-y","article-title":"The influence of dietary fats on insulin resistance","volume":"2","author":"Lovejoy","year":"2002","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.regpep.2012.08.006_bb0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11745-003-1038-4","article-title":"Sedentary lifestyle and risk of obesity and type 2 diabetes","volume":"38","author":"Hu","year":"2002","journal-title":"Lipids"},{"key":"10.1016\/j.regpep.2012.08.006_bb0035","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/jama.300.11.1303","article-title":"Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults","volume":"300","author":"Lang","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.regpep.2012.08.006_bb0040","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa0801869","article-title":"Clinical risk factors, DNA variants, and the development of type 2 diabetes","volume":"363","author":"Lyssenko","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.regpep.2012.08.006_bb0045","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11892-002-0098-y","article-title":"The influence of dietary fat on insulin resistance","volume":"2","author":"Lovejoy","year":"2002","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.regpep.2012.08.006_bb0050","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-012-2525-1","article-title":"Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence","author":"Johnson","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.regpep.2012.08.006_bb0055","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-012-2526-0","article-title":"Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer","author":"Renehen","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.regpep.2012.08.006_bb0060","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jama.298.10.1180","article-title":"Pioglitazone and risk of cardiovascular events in patients with type 1 diabetes mellitus","volume":"298","author":"Lincoff","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.regpep.2012.08.006_bb0065","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jama.2010.920","article-title":"Risk of acute myocardial infarction, stroke, heart failure, and death in elderly medicare patients treated with rosiglitazone or pioglitazone","volume":"304","author":"Graham","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.regpep.2012.08.006_bb0070","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.canlet.2011.08.010","article-title":"Cytotoxicity of troglitazone through PPAR\u03b3-independent pathway and p38 MAPK pathway in renal cell carcinoma","volume":"312","author":"Fujita","year":"2011","journal-title":"Cancer Lett"},{"key":"10.1016\/j.regpep.2012.08.006_bb0075","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1517\/14740338.2012.675326","article-title":"Anti-obesity drugs: a review about their effects and their safety","volume":"11","author":"Derosa","year":"2012","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.regpep.2012.08.006_bb0080","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/187221411797265917","article-title":"Novel approaches to the treatment of obesity and type 2 diabetes mellitus: bioactive leptin-related synthetic peptide analogs","volume":"5","author":"Grasso","year":"2011","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"10.1016\/j.regpep.2012.08.006_bb0085","unstructured":"P. Grasso, D.W. Lee, M.C. Leinung. Leptin-related, peptides. US7777388 (2004), US7186694 (2007), US7208752 (2007), US7290638 (2010), Australia772278 (2004)."},{"key":"10.1016\/j.regpep.2012.08.006_bb0090","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1210\/endo.138.4.5087","article-title":"In vivo effects of leptin-related synthetic peptides on body weight and food intake in female ob\/ob mice: localization of leptin activity to domains between amino acid residues 106 and 140","volume":"138","author":"Grasso","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.regpep.2012.08.006_bb0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0167-0115(99)00082-8","article-title":"Epitope mapping of secreted mouse leptin utilizing peripherally administered synthetic peptides","volume":"84","author":"Grasso","year":"1999","journal-title":"Regul Pept"},{"key":"10.1016\/j.regpep.2012.08.006_bb0110","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.2337\/diabetes.48.11.2204","article-title":"Inhibitory effects of leptin-related synthetic peptide 116\u2013130 on food intake and body weight gain in female C57BL\/6J ob\/ob mice may not be mediated by peptide activation of the long isoform of the leptin receptor","volume":"48","author":"Grasso","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2012.08.006_bb0120","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1210\/endo.141.7.7556","article-title":"Design of a synthetic leptin agonist: effects on energy balance, glucose homeostasis, and thermoregulation","volume":"141","author":"Rozhavskaya-Arena","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.regpep.2012.08.006_bb0125","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-0115(01)00274-9","article-title":"[D-Leu-4]-OB3, a synthetic leptin agonist, improves hyperglycemic control in C57BL\/6J ob\/ob mice","volume":"101","author":"Grasso","year":"2001","journal-title":"Regul Pept"},{"key":"10.1016\/j.regpep.2012.08.006_bb0130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1517\/17425247.3.4.529","article-title":"Intravail\u2122, highly effective intranasal delivery of peptide and protein drugs","volume":"3","author":"Maggio","year":"2006","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.regpep.2012.08.006_bb0135","doi-asserted-by":"crossref","first-page":"e8126","DOI":"10.1371\/journal.pone.0008126","article-title":"Prediction of pharmacological and xenobiotic responses to drugs based on time course gene expression profiles","volume":"4","author":"Huang","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.regpep.2012.08.006_bb0140","first-page":"48","article-title":"Reformulating injectables for oral delivery","volume":"35","author":"Greb","year":"2011","journal-title":"Pharm Technol"},{"key":"10.1016\/j.regpep.2012.08.006_bb0145","first-page":"54281","article-title":"(C10-C16) polyglycosides: exemptions from the requirement of a tolerance","volume":"70","author":"Alkyl","year":"2005","journal-title":"Fed Regist"},{"key":"10.1016\/j.regpep.2012.08.006_bb0150","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1023\/A:1013330815253","article-title":"Enhanced bioavailability of calcitonin formulated with alkylsaccharides following nasal and ocular administration in rats","volume":"18","author":"Ahsan","year":"2001","journal-title":"Pharm Res"},{"key":"10.1016\/j.regpep.2012.08.006_bb0155","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1210\/endo.135.6.7988421","article-title":"Insulin delivery in nosedrops: new formulations containing alkylglycosides","volume":"135","author":"Pillion","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.regpep.2012.08.006_bb0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0928-0987(03)00163-5","article-title":"Effects of the permeability enhancers tetradecylmaltoside and dimethyl-\u03b2-17 cyclodextrin, on insulin movement across human bronchial epithelial cells","volume":"20","author":"Ashan","year":"2003","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.regpep.2012.08.006_bb0165","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/jps.10171","article-title":"Nasal administration of low molecular weight heparin","volume":"91","author":"Arnold","year":"2002","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.regpep.2012.08.006_bb0170","doi-asserted-by":"crossref","first-page":"E846","DOI":"10.1152\/ajpendo.00030.2008","article-title":"Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes","volume":"294","author":"Cervera","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.regpep.2012.08.006_bb0175","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/j.biomaterials.2010.12.044","article-title":"The glucose lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo","volume":"22","author":"Nguyen","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.regpep.2012.08.006_bb0180","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.clinthera.2005.10.009","article-title":"Pramlintide in the treatment of type 1 and type 2 diabetes mellitus","volume":"26","author":"Ryan","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.regpep.2012.08.006_bb0185","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1463-1326.2009.01189.x","article-title":"Oral delivery of mouse [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, in male C57BL\/6J wild-type and ob\/ob mice: effects on energy balance, glycaemic control and serum osteocalcin levels","volume":"12","author":"Novakovic","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.regpep.2012.08.006_bb0190","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1463-1326.2010.01243.x","article-title":"Intranasal delivery of mouse [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, improves energy balance, glycaemic control, insulin sensitivity and bone formation in leptin-resistant C57BLK\/6-m db\/db mice","volume":"12","author":"Waldrop","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.regpep.2012.08.006_bb0195","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.regpep.2009.01.002","article-title":"Intranasal administration of mouse [D-Leu-4]-OB3, a synthetic peptide with leptin-like activity, enhances total uptake and bioavailability in Swiss Webster mice when compared to intraperitoneal, subcutaneous, and intramuscular delivery systems","volume":"154","author":"Novakovic","year":"2009","journal-title":"Regul Pept"},{"key":"10.1016\/j.regpep.2012.08.006_bb0200","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.regpep.2009.12.008","article-title":"Oral delivery of mouse [D-Leu-4]-OB3, a synthetic peptide with leptin-like activity, in male Swiss Webster mice: a study comparing the pharmacokinetics of oral delivery to intraperitoneal, subcutaneous, intramuscular, and intranasal delivery","volume":"160","author":"Lee","year":"2010","journal-title":"Regul Pept"},{"key":"10.1016\/j.regpep.2012.08.006_bb0205","first-page":"338","article-title":"Molecular basis and clinical application of biological markers of bone formation","volume":"17","author":"Calve","year":"1996","journal-title":"Endocr Rev"},{"key":"10.1016\/j.regpep.2012.08.006_bb0210","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.tem.2009.02.001","article-title":"Bone as an endocrine organ","volume":"20","author":"Fecundate","year":"2009","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.regpep.2012.08.006_bb0215","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.regpep.2011.02.009","article-title":"Oral delivery of octreotide acetate in Intravail\u00ae improves uptake, half-life, and bioavailability over subcutaneous administration in male Swiss Webster mice","volume":"167","author":"Maggio","year":"2011","journal-title":"Regul Pept"},{"key":"10.1016\/j.regpep.2012.08.006_bb0220","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1073\/pnas.0706473105","article-title":"Leptin responsiveness restored by amyl in agonist in diet-induced obesity: evidence from nonclinical and clinical studies","volume":"105","author":"Roth","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.regpep.2012.08.006_bb0225","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.physbeh.2010.02.023","article-title":"Multi-hormonal weight loss combination in diet-induced obese rats: therapeutic potential of cholecystokinin?","volume":"100","author":"Drivakis","year":"2010","journal-title":"Physiol Behav"},{"key":"10.1016\/j.regpep.2012.08.006_bb0230","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2337\/dc10-0518","article-title":"Leptin and amylin act in an additive manner to activate overlapping signaling pathways in peripheral tissues","volume":"34","author":"Moon","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.regpep.2012.08.006_bb0235","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1210\/en.2009-0546","article-title":"Mechanisms of amylin\/leptin synergy in rodent models","volume":"151","author":"Turek","year":"2010","journal-title":"Endocrinology"}],"container-title":["Regulatory Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011512002224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011512002224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T11:39:58Z","timestamp":1562153998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167011512002224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":44,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0167011512002224"],"URL":"https:\/\/doi.org\/10.1016\/j.regpep.2012.08.006","relation":{},"ISSN":["0167-0115"],"issn-type":[{"value":"0167-0115","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}